INFECTIONS IN ADULT LIVER-TRANSPLANT PATIENTS UNDER FK506 IMMUNOSUPPRESSION

被引：0
|
作者：
ALESSIANI, M
KUSNE, S
MARTIN, M
JAIN, A
ABUELMAGD, K
MOSER, J
TODO, S
FUNG, J
STARZL, T
机构：
[1] UNIV PITTSBURGH,CTR HLTH,DEPT SURG,PITTSBURGH,PA 15260
[2] VET ADM MED CTR,PITTSBURGH,PA
[3] UNIV PITTSBURGH,CTR HLTH,DEPT MED,PITTSBURGH,PA 15260
来源：
TRANSPLANTATION PROCEEDINGS | 1991年 / 23卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1501 / 1503
页数：3
相关论文
共 50 条
  • [1] FK506 AND PREGNANCY IN LIVER-TRANSPLANT PATIENTS
    JAIN, A
    VENKATARAMANAN, R
    LEVER, J
    WARTY, V
    FUNG, J
    TODO, S
    STARZL, T
    TRANSPLANTATION, 1993, 56 (03) : 751 - 751
  • [2] FK506 AND PREGNANCY IN LIVER-TRANSPLANT PATIENTS
    JAIN, A
    VENKATARAMANAN, R
    LEVER, J
    WARTY, V
    FUNG, J
    TODO, S
    STARZL, T
    TRANSPLANTATION, 1993, 56 (06) : 1588 - 1589
  • [3] PHARMACOKINETICS OF TACROLIMUS (FK506) IN LIVER-TRANSPLANT PATIENTS
    LEE, C
    JUSKO, W
    SHAEFER, M
    KLINTMALM, G
    HEBERT, M
    PIERGIES, A
    SCHECHTER, P
    MEKKI, Q
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1993, 53 (02) : 181 - 181
  • [4] POPULATION PHARMACOKINETICS OF TACROLIMUS (FK506) IN LIVER-TRANSPLANT PATIENTS
    MEKKI, QA
    LEE, C
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1994, 55 (02) : 162 - 162
  • [5] DIFFERENCES IN ORAL FK506 DOSE REQUIREMENTS BETWEEN ADULT AND PEDIATRIC LIVER-TRANSPLANT PATIENTS
    MCDIARMID, SV
    COLONNA, JO
    SHAKED, A
    VARGAS, J
    AMENT, ME
    BUSUTTIL, RW
    TRANSPLANTATION, 1993, 55 (06) : 1328 - 1332
  • [6] REVERSIBILITY OF NEPHROTOXICITY AND SEVERE GASTROINTESTINAL SYMPTOMS ASSOCIATED WITH FK506 IMMUNOSUPPRESSION IN LIVER-TRANSPLANT RECIPIENTS
    MOR, E
    KOLESNIKOV, V
    SHEINER, P
    SCHWARTZ, M
    EMRE, S
    MILLER, C
    HEPATOLOGY, 1993, 18 (03) : 734 - 734
  • [7] DIABETOGENICITY OF FK506 VERSUS CYA IN LIVER-TRANSPLANT RECIPIENTS
    JINDAL, RM
    EMRE, S
    MENESES, P
    MOR, E
    KADIAN, M
    KISHIKAWA, K
    SCHWARTZ, M
    MILLER, CM
    HEPATOLOGY, 1993, 18 (03) : 745 - 745
  • [8] DIABETOGENICITY OF FK506 VERSUS CYCLOSPORINE IN LIVER-TRANSPLANT RECIPIENTS
    JINDAL, RM
    POPESCU, I
    SCHWARTZ, ME
    EMRE, S
    BOCCAGNI, P
    MILLER, CM
    TRANSPLANTATION, 1994, 58 (03) : 370 - 372
  • [9] INTERACTION BETWEEN FK506 AND CLOTRIMAZOLE IN A LIVER-TRANSPLANT RECIPIENT
    MIELES, L
    VENKATARAMANAN, R
    YOKOYAMA, I
    WARTY, VJ
    STARZL, TE
    TRANSPLANTATION, 1991, 52 (06) : 1086 - 1087
  • [10] THE EFFECT OF FOOD ON ORAL BIOAVAILABILITY OF TACROLIMUS (FK506) IN LIVER-TRANSPLANT PATIENTS
    MEKKI, Q
    LEE, C
    CARRIER, S
    KLINTMAIM, G
    SHAEFER, M
    BURKE, P
    SCHECHTER, P
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1993, 53 (02) : 229 - 229
12345